87
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Co-delivery of docetaxel and p53 gene from cationic nanoparticles based on poly (l-lactide) and low-molecular-weight polyethyleneimine (PEA)

, , &
Pages 1049-1056 | Received 09 Apr 2022, Accepted 15 Nov 2022, Published online: 30 Nov 2022

References

  • Abuzar SM, Hyun S-M, Kim J-H, Park HJ, Kim M-S, Park J-S, Hwang S-J. 2018. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process. Int J Pharm. 538(1–2):1–13.
  • Blasi P. 2019. Poly (lactic acid)/poly (lactic-co-glycolic acid)-based microparticles: an overview. J Pharm Investig. 49(4):337–346.
  • Bonifati DM, Ori C, Rossi CR, Caira S, Fanin M, Angelini C. 2000. Neuromuscular damage after hyperthermic isolated limb perfusion in patients with melanoma or sarcoma treated with chemotherapeutic agents. Cancer Chemother Pharmacol. 46(6):517–522.
  • Bray F, Ferlay J, Laversanne M, Brewster DH, Gombe Mbalawa C, Kohler B, Pineros M, Steliarova-Foucher E, Swaminathan R, Antoni S, et al. 2015. Cancer incidence in five continents: inclusion criteria, highlights from Volume X and the global status of cancer registration. Int J Cancer. 137(9):2060–2071.
  • Cai FF, Luis MAF, Lin XY, Wang MH, Cai L, Cen CM, Biskup E. 2019. Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: preventive strategies and treatment (Review). Mol Clin Oncol. 11(1):15–23.
  • Cuadri AA, Martín-Alfonso JE. 2018. Thermomechanical degradation of PLA: a comparative study based on rheological, chemical and thermal properties. Polym Degrad Stabil. 150:37–45.
  • Elmowafy EM, Tiboni M, Soliman ME. 2019. Biocompatibility, biodegradation and biomedical applications of poly (lactic acid)/poly (lactic-co-glycolic acid) micro and nanoparticles. J Pharm Investig. 49(4):347–380.
  • Feng RM, Zong YN, Cao SM, Xu RH. 2019. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun (Lond). 39(1):22.
  • Guo QF, Li XL, Yang Y, Wei J, Zhao Q, Luo F, Qian ZY. 2014. Enhanced 4T1 Breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core–shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethyleneimine cationic nanoparticles. J Biomed Nanotechnol. 10(2):227–237.
  • Hu LL, Hu B, Shen LM, Zhang DD, Chen XW, Wang JH. 2015. Polyethyleneimine–iron phosphate nanocomposite as a promising adsorbent for the isolation of DNA. Talanta. 132:857–863.
  • Jeswani G, Chablani L, Gupta U, Sahoo RK, Nakhate, KT, Ajazuddin, . 2021. Development and optimization of paclitaxel loaded Eudragit/PLGA nanoparticles by simplex lattice mixture design: exploration of improved hemocompatibility and in vivo kinetics. Biomed Pharmacother. 144:112286.
  • Jiang CP, Chen JT, Li ZT, Wang ZT, Zhang WL, Liu JP. 2019. Recent advances in the development of polyethylenimine-based gene vectors for safe and efficient gene delivery. Expert Opin Drug Deliv. 16(4):363–376.
  • Jinturkar KA, Anish C, Kumar MK, Bagchi T, Panda AK, Misra AR. 2012. Liposomal formulations of etoposide and docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell lines. Biomaterials. 33(8):2492–2507.
  • Kalyane D, Raval N, Maheshwari R, Tambe V, Kalia K, Tekade RK. 2019. Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Mater Sci Eng C Mater Biol Appl. 98:1252–1276.
  • Kim IS, Lee SK, Park YM, Lee YB, Shin SC, Lee KC, Oh IJ. 2005. Physicochemical characterization of poly (l-lactic acid) and poly(d,l-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier. Int J Pharm. 298(1):255–262.
  • Mattiuzzi C, Lippi G. 2019. Current cancer epidemiology. J Epidemiol Glob Health. 9(4):217–222.
  • Miao QQ, Xie C, Zhen X, Lyu Y, Duan HW, Liu XG, Jokerst JV, Pu KY. 2017. Molecular afterglow imaging with bright, biodegradable polymer nanoparticles. Nat Biotechnol. 35(11):1102–1110.
  • Park SB, Lih E, Park KS, Joung YK, Han DK. 2017. Biopolymer-based functional composites for medical applications. Prog Polym Sci. 68:77–105.
  • Rebecca MH, Riccardo G, Robert L, Michael JM. 2020. Cyclodextrins in drug delivery: applications in gene and combination therapy. Drug Deliv Transl Res. 10:661–677.
  • Rezaee M, Oskuee RK, Nassirli H, Malaekeh-Nikouei B. 2016. Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems. J Control Release. 236:1–14.
  • Sun YX, Xiao W, Cheng SX, Zhang XZ, Zhuo RX. 2008. Synthesis of (Dex-HMDI)-g-PEIs as effective and low cytotoxic nonviral gene vectors. J Control Release. 128(2):171–178.
  • Sung YK, Kim SW. 2019. Recent advances in the development of gene delivery systems. Biomater Res. 23(8):8..
  • Tan LW, Peng JR, Zhao Q, Zhang L, Tang XC, Chen LJ, Lei MY, Qian ZY. 2017. A novel MPEG-PDLLA-PLL copolymer for docetaxel delivery in breast cancer therapy. Theranostics. 7(10):2652–2672.
  • Wang YJ, Chen LJ, Tan LW, Zhao Q, Luo F, Wei YQ, Qian ZY. 2014. PEG-ePCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy. Biomaterials. 35(25):6972–6985.
  • Ye J, Jiang XH, Dong ZH, Hu SH, Xiao M. 2019. Low-concentration PTX and RSL3 inhibits tumor cell growth synergistically by inducing ferroptosis in mutant p53 hypopharyngeal squamous carcinoma. Cancer Manag Res. 11:9783–9792.
  • Zhao J, Yang L, Huang P, Wang ZY, Tan Y, Liu H, Pan JJ, He CY, Chen ZY. 2016. Synthesis and characterization of low molecular weight polyethyleneimine-terminated Poly (β-amino ester) for highly efficient gene delivery of minicircle DNA. J Colloid Interface Sci. 463:93–98.
  • Zhou XY, Xu LQ, Xu JK, Wu JP, Kirk TB, Ma D, Xue W. 2018. Construction of a high-efficiency drug and gene co-delivery system for cancer therapy from a pH-sensitive supramolecular inclusion between oligoethylenimine-graft-β-cyclodextrin and hyperbranched polyglycerol derivative. ACS Appl Mater Interfaces. 10(42):35812–35829.
  • Zhu YY, Liao LM. 2015. Applications of nanoparticles for anticancer drug delivery: a review. J Nanosci Nanotechnol. 15(7):4753–4773.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.